Amgen
AMGN
1,435 hedge funds and large institutions have $89.5B invested in Amgen in 2016 Q1 according to their latest regulatory filings, with 97 funds opening new positions, 599 increasing their positions, 498 reducing their positions, and 100 closing their positions.
20% more repeat investments, than reductions
Existing positions increased: 599 | Existing positions reduced: 498
3% less first-time investments, than exits
New positions opened: 97 | Existing positions closed: 100
1% less funds holding
Funds holding: 1,454 → 1,435 (-19)
9% less capital invested
Capital invested by funds: $98.6B → $89.5B (-$9.08B)
17% less call options, than puts
Call options by funds: $752M | Put options by funds: $911M
24% less funds holding in top 10
Funds holding in top 10: 112 → 85 (-27)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal London Asset Management
United Kingdom
|
+$4.08B |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$277M |
| 3 |
Winslow Capital Management
Minneapolis,
Minnesota
|
+$207M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$200M |
| 5 |
Aristotle Capital Management
Los Angeles,
California
|
+$197M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TP
Third Point
New York
|
-$898M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$399M |
| 3 |
BNP Paribas Financial Markets
Paris,
France
|
-$127M |
| 4 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$126M |
| 5 |
CLM
ClearBridge LLC (Maryland)
Baltimore,
Maryland
|
-$122M |
AMGN Hedge Fund Activity: Q1 2016 in Review
1,435 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q1 2016, worth a combined $89.5B — down 9.2% from $98.6B a quarter earlier.
Sellers outnumbered buyers: 100 funds closed out of AMGN and 97 opened new positions — a net loss of 3 holders — while 498 trimmed existing stakes and 599 added.
The largest buyer was Royal London Asset Management, adding an estimated $4.08B. The largest seller was Third Point, cutting an estimated $898M.
- 1,435 institutional investors held Amgen (AMGN) as of Q1 2016, down from 1,454 in Q4 2015.
- Funds reported $89.5B of Amgen stock for Q1 2016, down 9.2% quarter-over-quarter.
- 97 funds opened new Amgen positions in Q1 2016 and 100 closed out, a net change of -3 holders.
- The largest Amgen buyer in Q1 2016 was Royal London Asset Management, an estimated $4.08B added.
- The largest Amgen seller in Q1 2016 was Third Point, an estimated $898M sold.
Based on aggregated 13F filings for Q1 2016.